Methods, Systems and Computer Programs for Assessing CHD Risk Using Adjusted HDL Particle Number Measurements
AssigneeLipoScience, Inc.
InventorJames D. Otvos
Life of this patent
Estimating the term…
Abstract
Methods, computer program products and apparatus determine a subject's risk of having or developing CHD using a calculated HDL particle risk number and/or a mathematical model of risk associated with HDL particles that adjusts concentrations of at least one of the subclasses of small, medium and large HDL particle measurements to reflect predicted CHD risk. A calculated LDL particle risk number may also be generated as well as a lipoprotein particle index derived from the ratio of RLDL/RHDL.
Claims18
A method of determining a subject's risk of having and/or developing CHD, comprising:
- obtaining concentration measurements of small and large HDL subclass particles in a biosample;
- programmatically adjusting the obtained value of the small HDL subclass particle concentration measurement, the large HDL subclass particle concentration measurement, or the concentration measurements of both small and large HDL subclass particles;
- and
- determining a subject's risk of having and/or developing CHD based on the adjusted HDL subclass particle concentration measurement.
2-3. (canceled)
9-12. (canceled)
(canceled)
(canceled)
A computer program product for adjusting measured in vitro concentrations of HDL particles to assess CHD risk, the computer program product comprising:
- a computer readable storage medium having computer readable program code embodied in said medium, said computer readable program code comprising:
- computer readable program code that adjusts measured in vitro concentrations of small HDL subclass particles, large HDL subclass particles, or the concentration measurements of both small and large HDL subclass particles to generate an HDL risk number to reflect a subject's risk of having or developing CHD.
18-27. (canceled)
A system for obtaining data regarding lipoprotein constituents in a subject, comprising:
- an NMR spectrometer for acquiring at least one NMR spectrum of an in vitro biosample;
- and
- a controller in communication with the NMR spectrometer, the controller comprising a computer readable storage medium having computer readable program code embodied in the medium, the computer-readable program code comprising:
- computer program code for determining concentrations of small and large HDL subclass particles in the biosample undergoing analysis;
- and
- computer program code for adjusting of the determined concentration of small subclass particles, large HDL subclass particles or the determined concentration of both small and large HDL subclass particles to determine a risk of the subject developing or having CHD.
31-42. (canceled)
Dependencies are inferred from the claim text.